HUTCHMED (China) (HCM) Stock Highlights

15.6 | +12.31%

2025-04-23 04:01:04

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.

Statistics

Range Today

15.08 15.88

Volume Today 166.7K

Range 1 Year

11.51 21.92

Volume 1 Year 26.67M

Range 3 Year

7.39 21.92

Volume 3 Year 173.35M

Range 10 Year

7.39 43.94

Volume 10 Year 465.18M

Highlights

Market Capitalization 2.35B (mid)

Floating Shares 504.59M

Current Price 15.6

Price To Earnings 68.9

Price To Revenue 17.5

Price To Book 15.48

Earnings Per Share 0.2

Payout Ratio 0%

Performance

Latest +12.31%

1 Month +3.59%

3 Months +11.35%

6 Months -25.29%

1 Year -7.03%

3 Years -5.05%

5 Years -22.16%

10 Years +15.56%

Benchmarks

Market Capitalization

62 / 368

Gross Profits

270 / 278

Total Revenue

21 / 300

Total Rank

145 / 368

Free Cashflow

277 / 352

Performance 5 years

131 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.